The MajesTEC-7 clinical research study
Learn about this study for adults with newly diagnosed multiple myeloma.
The MajesTEC-7 clinical research study
Learn about this study for adults with newly diagnosed multiple myeloma.
The MajesTEC-7 study is evaluating two investigational medications for adults with newly diagnosed multiple myeloma who are either unable to receive a stem cell transplant or are not receiving one as initial therapy.
If you are eligible, you may receive:
- One of the investigational medications + standard multiple myeloma medications
- Standard multiple myeloma medications only
All study medication will be given during repeating 28-day cycles.
Study doctors want to determine the safety and efficacy of two investigational medications when each is combined with standard medications for multiple myeloma.
The two investigational medication combinations will be compared with standard multiple myeloma medications alone.
The results of this study may provide more information about the combination of standard of care medications with investigational medications.
Multiple myeloma is a cancer that develops in the bone marrow. This part of the body produces blood cells to fight infections.
When cancer cells overtake the bone marrow, it can’t produce enough healthy blood cells to fight infections. Without healthy blood cells, a person can experience serious health issues.
The Patient brochure provides detailed information about the MajesTEC-7 study. Download this resource to learn about the purpose of the study, who can participate, what to expect during the study, and general information about clinical research.
The patient and caregiver brochure provides detailed information about the MajesTEC-7 study for caregivers. Download this resource to learn about the purpose of the study, who can participate, what caregivers can expect, and general information about clinical research.
See if you may qualify
Answer the following questions to see if you or someone you know may be eligible to take part in this study.
Please keep in mind: Even if you believe you meet the eligibility criteria, joining a clinical research study is not guaranteed. Whether you’re referred or able to take part depends on a review by a qualified healthcare professional. This questionnaire is intended for United States participants only.
Note about privacy: Email responses may not be encrypted. This means there’s a chance the messages could be seen by someone other than the intended recipient. We will avoid including sensitive personal information in emails whenever possible. However, we cannot guarantee that no sensitive information will be revealed indirectly.
About your information:
With your consent, we will use your answers to help determine whether you may be eligible for this clinical trial. You can withdraw your consent at any time.
Your information may be transferred to countries outside your country of residence, including the United States, which may have different data protection rules.
If you submit any personal information about someone else, you confirm that you have permission to do so.
Please read our Privacy policy for more details.